Compare CSW & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSW | PTCT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.5B |
| IPO Year | 2014 | 2006 |
| Metric | CSW | PTCT |
|---|---|---|
| Price | $295.48 | $60.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $351.86 | $97.94 |
| AVG Volume (30 Days) | 89.8K | ★ 1.0M |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.41% | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | ★ 3.04 | 0.90 |
| Revenue | ★ $1,082,549,000.00 | $264,734,000.00 |
| Revenue This Year | $18.51 | N/A |
| Revenue Next Year | $4.26 | $9.47 |
| P/E Ratio | $97.07 | ★ $69.81 |
| Revenue Growth | 23.25 | ★ 36.19 |
| 52 Week Low | $236.66 | $58.80 |
| 52 Week High | $355.48 | $90.87 |
| Indicator | CSW | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 40.74 |
| Support Level | $282.14 | $58.80 |
| Resistance Level | $293.90 | $69.62 |
| Average True Range (ATR) | 8.19 | 2.11 |
| MACD | 0.99 | 0.25 |
| Stochastic Oscillator | 52.06 | 27.82 |
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms & domain expertise across three segments: Contractor Solutions, Engineered Building Solutions, & Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient & performance-enhancing products for residential & commercial HVAC/R & plumbing applications, which are designed for professional end-use customers. The majority of the company's revenue is generated from the Contractor Solutions segment in the U.S. markets. products include mechanical products for heating, ventilation, air conditioning, & refrigeration, plumbing products, grilles, registers, & diffusers, building safety solutions, & high-performance specialty lubricants & sealants.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.